U.S. drugmaker Eli Lilly has signed a research deal with privately held AI-focused firm Genetic Leap to develop genetic ...
UTHealth Houston unveiled a partnership with OpenAI on Friday to build and deploy algorithms for use in medical training and ...
In the weeks leading up to the release of OpenAI’s newest “reasoning” model, o1, independent AI safety research firm Apollo Research found a notable issue. It realized the model produced ...
In all, the partners plan to provide enough supply to cover every eligible infant in the U.S. Sanofi has begun shipping the antibody in its 50 mg and 100 mg doses to private healthcare providers ...
According to deal terms announced Thursday, Sanofi is paying €100 million (about $110 million) to license AlphaMedix, a radiopharmaceutical developed by partners RadioMedix and Orano Med.
Sanofi is paying $175 million upfront to claim a share of an experimental vaccine developed by Johnson & Johnson’s pharma unit Janssen that aims to tackle a major cause of blood infections.
After talks with OpenAI fell apart, Mumsnet in July announced its intention to pursue legal action. According to Mumsnet, during those early conversations, an OpenAI strategic partnership lead ...
CD&R is competing for the Sanofi business with French rival PAI Partners, with bids due this month. Most Read from Bloomberg Businessweek College Football Players Learn an Ugly Truth About Getting ...
OpenAI has announced a new partnership with media publisher Condé Nast. The partnership will see OpenAI’s ChatGPT and SearchGPT displaying content from titles such as Vogue, The New Yorker ...
Since my last article, Sanofi’s stock price has continued to rise, thanks in part to strong sales of its immunology and oncology franchises. For example, Dupixent sales were €3.03 billion for ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Clayton Dubilier & Rice is discussing the possibility of using borrowed money to fund a part of the equity check in its bid for Sanofi’s €15 billion ($16.6 billion) consumer health division ...